CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. PURCHASE AND SALE AGREEMENT BY AND AMONG ALBIREO PHARMA,...Purchase and Sale Agreement • November 8th, 2022 • Albireo Pharma, Inc. • Pharmaceutical preparations • New York
This PURCHASE AND SALE AGREEMENT, dated as of September 22, 2022 (this “Agreement”), is made and entered into by and among (i) Sagard Healthcare Partners (Delaware) LP, a Delaware limited partnership (“Buyer”), (ii) Albireo Pharma, Inc., a Delaware corporation (“Albireo Pharma”), and (iii) Albireo AB, a company incorporated under the laws of Sweden with registration number 556737-4631 (each of Albireo Pharma and Albireo AB, a “Seller” and, collectively, the “Sellers”).
